StonvexLoading…
StonvexStonvexStonvexCore line items from FDX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Annual 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $69.71B | $45.71B | $22.24B | $87.93B |
Operating Income | $3.91B | $2.56B | $1.19B | $5.22B |
Net Income | $2.84B | $1.78B | $824.00M | $4.09B |
EPS (Diluted) | $11.91 | $7.50 | $3.46 | $16.81 |
Total Assets | $94.73B | $89.18B | $88.42B | $87.63B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $8.01B | $6.57B | $6.17B | $5.50B |
Free Cash Flow OCF − CapEx | $3.33B | $2.29B | $1.09B | $2.98B |
Shares Outstanding | 238.00M | 237.00M | 238.00M | 243.00M |